780 related articles for article (PubMed ID: 28600913)
41. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.
Ehrhardt NM; Chellappa M; Walker MS; Fonda SJ; Vigersky RA
J Diabetes Sci Technol; 2011 May; 5(3):668-75. PubMed ID: 21722581
[TBL] [Abstract][Full Text] [Related]
42. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing.
Allen BT; DeLong ER; Feussner JR
Diabetes Care; 1990 Oct; 13(10):1044-50. PubMed ID: 2170088
[TBL] [Abstract][Full Text] [Related]
43. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
44. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
Diabetes Technol Ther; 2018 Apr; 20(4):274-284. PubMed ID: 29608107
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
[TBL] [Abstract][Full Text] [Related]
46. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
[No Abstract] [Full Text] [Related]
47. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.
Polonsky WH; Fisher L; Schikman CH; Hinnen DA; Parkin CG; Jelsovsky Z; Axel-Schweitzer M; Petersen B; Wagner RS
Diabetes Technol Ther; 2011 Aug; 13(8):797-802. PubMed ID: 21568751
[TBL] [Abstract][Full Text] [Related]
48. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study.
Sia HK; Kor CT; Tu ST; Liao PY; Wang JY
Sci Rep; 2021 Jan; 11(1):1176. PubMed ID: 33441946
[TBL] [Abstract][Full Text] [Related]
49. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.
Tanenberg R; Bode B; Lane W; Levetan C; Mestman J; Harmel AP; Tobian J; Gross T; Mastrototaro J
Mayo Clin Proc; 2004 Dec; 79(12):1521-6. PubMed ID: 15595336
[TBL] [Abstract][Full Text] [Related]
50. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial.
Di Bartolo P; Nicolucci A; Cherubini V; Iafusco D; Scardapane M; Rossi MC
Acta Diabetol; 2017 Apr; 54(4):393-402. PubMed ID: 28138788
[TBL] [Abstract][Full Text] [Related]
51. The Efficacy and Frequency of Self-monitoring of Blood Glucose in Non-insulin-Treated T2D Patients: a Systematic Review and Meta-analysis.
Zou Y; Zhao S; Li G; Zhang C
J Gen Intern Med; 2023 Feb; 38(3):755-764. PubMed ID: 36403159
[TBL] [Abstract][Full Text] [Related]
52. A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.
Di Molfetta S; Patruno P; Cormio S; Cignarelli A; Paleari R; Mosca A; Lamacchia O; De Cosmo S; Massa M; Natalicchio A; Perrini S; Laviola L; Giorgino F
J Endocrinol Invest; 2022 Sep; 45(9):1663-1671. PubMed ID: 35476320
[TBL] [Abstract][Full Text] [Related]
53. Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
Wysham C; Bhargava A; Chaykin L; de la Rosa R; Handelsman Y; Troelsen LN; Kvist K; Norwood P
JAMA; 2017 Jul; 318(1):45-56. PubMed ID: 28672317
[TBL] [Abstract][Full Text] [Related]
54. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
[TBL] [Abstract][Full Text] [Related]
55. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
Zhang DA; Katznelson L; Li M
J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
[TBL] [Abstract][Full Text] [Related]
56. Self-glucose monitoring and glycaemic control at a tertiary care university hospital, Karachi, Pakistan.
Khowaja K; Waheed H
J Pak Med Assoc; 2010 Dec; 60(12):1035-8. PubMed ID: 21381559
[TBL] [Abstract][Full Text] [Related]
57. Patient Perspectives on Self-Monitoring of Blood Glucose When not Using Insulin: a Cross-sectional Survey.
Pfoh ER; Linfield D; Speaker SL; Roufael JS; Yan C; Misra-Hebert AD; Rothberg MB
J Gen Intern Med; 2022 May; 37(7):1673-1679. PubMed ID: 34389935
[TBL] [Abstract][Full Text] [Related]
58. The Impact of Structured Self-Monitoring of Blood Glucose Combined With Intensive Education on HbA1c Levels, Hospitalizations, and Quality-of-Life Parameters in Insulin-Treated Patients With Diabetes at Primary Care in Serbia: The Multicenter SPA-EDU Study.
Lalić NM; Lalić K; Jotić A; Stanojević D; Živojinović D; Janićijević A; Parkin C;
J Diabetes Sci Technol; 2017 Jul; 11(4):746-752. PubMed ID: 28625073
[TBL] [Abstract][Full Text] [Related]
59. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
[TBL] [Abstract][Full Text] [Related]
60. The impact of blood glucose monitoring on depression and distress in insulin-naïve patients with type 2 diabetes.
Fisher L; Polonsky W; Parkin CG; Jelsovsky Z; Amstutz L; Wagner RS
Curr Med Res Opin; 2011 Nov; 27 Suppl 3():39-46. PubMed ID: 21916532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
